Valuation PharmaEngine, Inc.

Stocks

End-of-day quote Taipei Exchange 2026-08-14			5-day change	1st Jan Change
62.10 ^TWD	-2.36%		-2.51%	-11.79%

08-06	PharmaEngine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025
Market Cap ¹	8,430	10,207	17,961	15,158	12,974	10,115
Change	-	21.08%	75.96%	-15.6%	-14.41%	-22.04%
Enterprise Value (EV) ¹	5,058	6,401	14,322	11,545	9,120	5,440
Change	-	26.55%	123.74%	-19.39%	-21%	-40.35%
P/E	14x	24.7x	56.3x	55.2x	7.42x	26.2x
PBR	2.1x	2.65x	4.64x	3.92x	2.4x	2.05x
PEG	-	-0.9x	-2.3x	-4x	0x	-0.3x
Capitalization / Revenue	7.98x	15.6x	27.4x	19.7x	5.14x	11.1x
EV / Revenue	4.79x	9.78x	21.9x	15x	3.61x	5.97x
EV / EBITDA	6.24x	17.6x	50.5x	41.4x	4.44x	12.7x
EV / EBIT	6.25x	17.6x	50.7x	41.7x	4.44x	12.8x
EV / FCF	-100x	8.84x	136x	72.2x	-464x	3.36x
FCF Yield	-1%	11.3%	0.74%	1.38%	-0.22%	29.7%
Dividend per Share ²	2.535	2.7	2	1.5	6	2
Rate of return	4.38%	3.72%	1.6%	1.42%	6.64%	2.84%
EPS ²	4.14	2.94	2.22	1.91	12.17	2.69
Distribution rate	61.2%	91.8%	90.1%	78.5%	49.3%	74.3%
Net sales ¹	1,056	654.8	654.4	767.7	2,523	911.4
EBITDA ¹	811.3	363.4	283.4	278.5	2,055	427.2
EBIT ¹	809.7	362.7	282.7	277.2	2,053	425.5
Net income ¹	604.3	426	318.8	274.6	1,751	387.6
Net Debt ¹	-3,372	-3,806	-3,639	-3,613	-3,854	-4,675
Reference price ²	57.90	72.60	125.00	105.50	90.30	70.40
Nbr of stocks (in thousands)	145,597	140,596	143,687	143,679	143,678	143,678
Announcement Date	3/24/21	3/18/22	3/17/23	3/12/24	3/7/25	3/21/26

¹TWD in Million²TWD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
PHARMAENGINE, INC.	-	-	-	-	279M
LONZA GROUP AG	33.04x	5.91x	17.56x	0.97%	48.42B
REVOLUTION MEDICINES, INC.	-21.14x	288.75x	-21.43x	-.--%	43.66B
BEONE MEDICINES AG	45.52x	5.25x	28.69x	-.--%	39.51B
IQVIA HOLDINGS INC.	30.48x	3.03x	13.08x	-.--%	38.95B
CELLTRION, INC.	30.58x	8.82x	22.17x	0.38%	32.61B
MEDPACE HOLDINGS, INC.	32.9x	5.38x	24.45x	-.--%	16.15B
EUROFINS SCIENTIFIC SE	23.48x	2.05x	8.89x	1.15%	14.16B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	74.93x	3.96x	15.35x	-.--%	13.37B
Average	31.22x	40.39x	13.59x	0.31%	27.46B
Weighted average by Cap.	26.43x	55.41x	12.18x	0.31%